Stockscreener 앱 받기
2.00
2.44%
-0.05
시장 영업 전:
2.00
전일 마감가:
$2.05
열려 있는:
$2.05
하루 거래량:
623.68K
Relative Volume:
0.83
시가총액:
$135.53M
수익:
-
순이익/손실:
$-64.20M
주가수익비율:
-0.9302
EPS:
-2.15
순현금흐름:
$57,000
1주 성능:
-4.76%
1개월 성능:
+1.01%
6개월 성능:
+57.48%
1년 성능:
-47.64%
1일 변동 폭
$1.93
$2.10
1주일 범위
$1.93
$2.18
52주 변동 폭
$1.05
$4.34
Climb Bio Inc Stock (CLYM) Company Profile
명칭
Climb Bio Inc
전화
1-866-857-2596
주소
20 WILLIAM STREET, WELLESLEY HILLS
CLYM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CLYM
Climb Bio Inc
|
2.00 | 138.92M | 0 | -64.20M | 57,000 | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Climb Bio Inc Stock (CLYM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-16 | 개시 | William Blair | Outperform |
| 2025-10-13 | 개시 | H.C. Wainwright | Buy |
| 2025-08-15 | 개시 | Robert W. Baird | Outperform |
| 2025-06-06 | 개시 | Oppenheimer | Outperform |
| 2025-05-22 | 개시 | BTIG Research | Buy |
| 2024-12-02 | 개시 | Leerink Partners | Outperform |
모두보기
Climb Bio Inc 주식(CLYM)의 최신 뉴스
How sustainable is Climb Bio Inc. stock dividend payoutEarnings Beat & Risk Controlled Swing Trade Alerts - newser.com
Will Climb Bio Inc. stock go up soonWeekly Loss Report & AI Based Buy/Sell Signal Reports - newser.com
Can Climb Bio Inc. stock maintain operating margins2025 Market Outlook & Fast Momentum Stock Entry Tips - newser.com
Visualizing Climb Bio Inc. stock with heatmapsJuly 2025 Levels & Low Drawdown Momentum Ideas - newser.com
Momentum divergence signals in Climb Bio Inc. chartSell Signal & Verified Stock Trade Ideas - newser.com
Can momentum traders help lift Climb Bio Inc.2025 Trade Ideas & Stepwise Trade Signal Implementation - newser.com
Climb Bio to Present at Upcoming Investor Conferences - The Manila Times
Is Climb Bio Inc. stock entering bullish territoryTrend Reversal & Trade Opportunity Analysis - newser.com
Climb Bio (Nasdaq: CLYM) to join Guggenheim, Baird and Piper Sandler events; webcasts - Stock Titan
Why Climb Bio Inc. stock is recommended by analysts2025 Earnings Surprises & Stepwise Trade Signal Implementation - newser.com
Using R and stats models for Climb Bio Inc. forecastingWeekly Stock Report & Community Consensus Stock Picks - newser.com
Predicting Climb Bio Inc. trend using moving averagesQuarterly Trade Summary & Advanced Swing Trade Entry Alerts - newser.com
Strategies to average down on Climb Bio Inc.Analyst Downgrade & Reliable Price Action Trade Plans - newser.com
Has Climb Bio Inc. formed a bullish divergenceMarket Rally & Risk Managed Investment Strategies - newser.com
What institutional flow reveals about Climb Bio Inc.Weekly Investment Summary & Community Consensus Stock Picks - newser.com
William Blair Initiates Coverage of Climb Bio (CLYM) with Outperform Rating on Autoimmune Drug Potential - Insider Monkey
10 Best Stocks Under $3 to Invest In - Insider Monkey
Climb Bio, Inc. (NASDAQ:CLYM) Given Average Recommendation of "Buy" by Brokerages - MarketBeat
Climb Bio’s Promising Phase 1b Study on Budoprutug for Lupus: A Market Game-Changer? - TipRanks
Climb Bio’s Phase 2 Study on Budoprutug: A Potential Game-Changer in Nephrology - TipRanks
Will Climb Bio Inc. stock remain a Wall Street favoriteJuly 2025 Market Mood & Risk Managed Investment Signals - Fundação Cultural do Pará
Climb Bio’s Promising ITP Study: A Potential Game-Changer for Investors - TipRanks
Climb Bio Inc (CLYM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.64%
0.35%
자본화:
|
볼륨(24시간):